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INTRODUCTION
The incidence of pulmonary disease caused by nontubercu-
lous mycobacteria (NTM) in HIV-negative patients is increas-
ing worldwide (1-3). A substantial proportion of these pati-
ents has no predisposing risk factors, such as pre-existing lung
disease or demonstrable immunodeficiency. These patients
are predominantly elderly women with no history of smok-
ing who complain of chronic cough and sputum (1-3). Chest
high-resolution computed tomography (HRCT) scans reveal
characteristic findings of bilateral multifocal bronchiolitis
(well-defined small nodules and branching centrilobular nod-
ules, or tree-in-bud pattern) and bronchiectasis (4-9). Mycobac-
terium avium complex (MAC) and Mycobacterium abscessus are
well-recognized organisms that cause these forms of NTM
lung disease (4-9).
Although NTM infection is the most common cause of
bilateral bronchiectasis combined with tree-in-bud pattern of
bronchiolitis, these computed tomography (CT) finding are
not specific for NTM lung disease. Indeed, the clinical and
CT findings of diffuse panbronchiolitis (DPB) are similar to
those reported for patients with NTM lung disease. DPB is
a chronic inflammatory lung disease of unknown cause which
is prevalent in East Asia, including Japan and Korea (10).
Patients with DPB have chronic cough, sputum, and dysp-
nea. In addition, the CT findings in patients with DPB are
diffuse, small, round and linear opacities, dilatation of the
small bronchi and bronchioles, and bronchial wall thicken-
ing (11, 12). Therefore, the clinical symptoms of patients
with the nodular bronchiectatic form of NTM lung disease
or DPB are often nonspecific and radiographic findings are
very similar in both disease. Recently, our group found that
the most common identifiable cause of CT findings of bilat-
eral bronchiectasis and bronchiolitis was NTM lung disease;
and DPB was the second most common cause (7).
Despite the similarity between the clinical and radiograph-
ic features of NTM lung disease and DPB, the treatment of
these two diseases is very different. DPB is highly respon-
sive to treatment with low-dose macrolide therapy (10, 13),
while the treatment of NTM lung disease requires the use
of multiple antibiotics, including macrolides, for a prolonged
duration (1, 2). If patients with NTM lung disease were given
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Comparison of Clinical and Radiographic Characteristics between
Nodular Bronchiectatic Form of Nontuberculous Mycobacterial Lung
Disease and Diffuse Panbronchiolitis
The nodular bronchiectatic form of nontuberculous mycobacterial (NTM) lung dis-
ease and diffuse panbronchiolits (DPB) show similar clinical and radiographic find-
ings. The present study was performed to clarify the clinicoradiographic similarities
as well as the differences between NTM lung disease and DPB. The initial clinico-
radiographic features of 78 patients with the nodular bronchiectatic form of NTM
lung disease (41 patients with Mycobacterium avium complex infection and 37 pa-
tients with Mycobacterium abscessus infection) were compared with those of 35
patients with DPB. Old age, female sex, a history of tuberculosis treatment, and
hemoptysis were related to NTM lung disease while exertional dyspnea, coarse
crackles, history of sinusitis, obstructive abnormalities in pulmonary function tests,
and hypoxemia were related to DPB. The number of lobes involved with bronchi-
olitis and bronchiectasis on chest computed tomography were more numerous in
DPB patients. There is considerable overlap in the clinical and radiographic appear-
ances of the nodular bronchiectatic form of NTM lung disease and DPB, although
some clinicoradiographic features differ between two diseases. The correct diag-
nosis, including aggressive microbiologic evaluation, should be made for the appro-
priate management of patients presenting with bilateral bronchiectasis and bron-
chiolitis.
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Accepted : 25 July 2008macrolide monotherapy, it could result in the development
of macrolide-resistant NTM lung disease (14). Hence, an
initial discrimination between patients with NTM lung dis-
ease and those with DPB is very important. Unfortunately,
no clinical studies were performed to identify clinical or radio-
graphic characteristics helpful for differentiating NTM lung
disease from DPB. In this study, we compared the clinical
and radiographic characteristics of the two diseases to deter-
mine differences between the nodular bronchiectatic form
of NTM lung disease and DPB.
MATERIALS AND METHODS
Patients
This study, to review and publish patient records retrospec-
tively, was approved by the Institutional Review Board of
Samsung Medical Center. Seventy-eight patients with the
nodular bronchiectatic form of NTM lung disease who were
newly diagnosed at the Samsung Medical Center (a 1,250-
bed referral hospital in Seoul, Korea) between January 2004
and December 2005 were retrospectively studied. All patients
had characteristic findings on HRCT scans, such as bilateral
bronchiectasis combined with multiple small nodules and
branching linear structures (4-9). The diagnosis of NTM lung
disease was made when the patient fulfilled the clinical, radio-
graphic, and microbiological diagnostic criteria published
by the American Thoracic Society (1). Of 78 patients, 41 were
identified as having MAC infection and 37 patients were
identified as having M. abscessus infection. None of the patients
had malignancy and positive results of testing for antibodies
to HIV. 
Thirty-five patients with DPB who were diagnosed between
January 1995 and December 2005 were also retrospectively
studied. The diagnosis of DPB was made when the patient
met the diagnostic criteria of the Ministry of Health and Wel-
fare of Japan (10), or were confirmed by surgical lung biop-
sy (n=7). 
The diagnostic criteria were as follows: 
1) Persistent cough, sputum, and exertional dyspnea.
2) Past history of or current chronic sinusitis.
3) Bilateral, diffuse, small nodular shadows on a plain chest
radiography film or centrilobular nodular shadows on
chest CT images.
4) Coarse crackles.
5) FEV1/FVC less than 70% and PaO2less than 80 mmHg.
6) Titer of cold hemagglutinin equal to or higher than 64.
Definitive cases fulfilled the first three criteria listed above
(number 1-3) and at least two of the latter three criteria (num-
ber 4-6) (10). None of the patients, diagnosed as DPB from
this study, had smear and culture positive specimens in spu-
tum or bronchoalveolar lavage fluid for acid-fast bacilli. 
Evaluation of clinical and radiographic characteristics
The medical records of all patients studied were reviewed
and included information regarding gender, age at diagno-
sis, body mass index, respiratory symptoms and signs, his-
tory of smoking, history of treatment for tuberculosis, his-
tory of sinusitis, and routine laboratory tests including white
blood cell counts (WBC), hemoglobin (Hb), albumin, C-
reactive protein (CRP), rheumatoid factor, cold agglutinin,
immunoglobulins (Ig), pulmonary function test results, and
arterial blood gas analyses. 
Chest radiography films were assessed in the presence of
cavitation and nodular/reticulonodular lesions. For the pur-
pose of analysis, we divided each lung into three zones. Lesions
such as cavitation or nodular/reticulonodular opacities were
considered to be in the upper zone of the lung if they were
cephalad to the aortic arch, in the lower zone if they were cau-
dad to the inferior pulmonary vein, and in the middle zone
if they were observed between the two other zones. Distribu-
tion of the lesions was further classified as 1) lesions observed
only in the upper lung zone(s), 2) lesions observed only in
the middle and/or lower lung zone(s), and 3) lesions observed
in the both zone(s). 
A total of six lobes in each patient’s lung (the lingular seg-
ment was considered as a separate lobe) were assessed for the
presence of lung lesions and other abnormal findings on chest
HRCT scans. Each lobe was evaluated with regard to the
presence or absence of bronchiectasis, well-defined small nod-
ules (<10 mm in diameter), and branching centrilobular nod-
ules (i.e., the tree-in-bud pattern). Bronchiolitis was defined
as the presence of well-defined small nodules and branching
centrilobular nodules on chest HRCT scans. The extent of
involvement of bronchiectasis and bronchiolitis was estimated
by counting the number of lobes involved. The presence of
cavitation was also recorded.
Statistical analysis
Values are expressed as the mean±standard deviation. The
unpaired t test was used to statistically evaluate differences
in continuous variables between the two groups. Frequencies
were analyzed using the chi-square test or the Fisher exact
test, as appropriate. A difference with a P value of less than
0.05 was considered statistically significant. 
RESULTS
Comparisons of clinical characteristics
As shown in Table 1, patients with NTM lung disease were
of older age (58±14 vs. 50±17 yr, P=0.008), showed a
female predilection (82% vs. 26%, P<0.001), and were more
likely to have a history of tuberculosis treatment (56% vs.
428 H.Y. Park, G.Y. Suh, M.P. Chung, et al.11%, P<0.001) compared with those with DPB. A past
history of or current chronic sinusitis was more common in
patients with DPB (100%) than in those with NTM lung
disease (26%, P<0.001).
The main presenting symptoms were cough and sputum
in both groups. Hemoptysis was more common in patients
with NTM lung disease (56% vs. 31%, P=0.017), while exer-
tional dyspnea (97% vs. 26%, P<0.001) and coarse crackles
(100% vs. 54%, P<0.001) were more common in patients
with DPB. 
The results of laboratory findings are summarized in Table
2. The WBC counts of peripheral blood and the serum lev-
els of CRP and IgA were significantly higher in patients with
DPB than in those with NTM lung disease. The proportion
of patients who had a titer of cold hemagglutinin ≥64 was
also higher in patients with DPB. The patients with FEV1/
FVC <70%, or arterial oxygenation <80 mmHg were more
commonly diagnosed with DPB than NTM. 
Comparison of radiographic characteristics
The most common chest radiography finding was the pres-
ence of reticulonodular opacities, which were seen in all pa-
tients with NTM lung disease and DPB. The laterality and
distribution of chest radiography abnormalities were very
similar in both diseases; the opacities were bilateral in 90%
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NTM lung 
disease
(n=78)
NTM lung 
disease
(n=78)
DPB 
(n=35)
P value
NTM lung 
disease
(n=78)
DPB 
(n=35)
P value
Age (yr) 58±14 50±17 0.008
Sex, Female  64 (82%) 9 (26%) <0.001
Body mass index (kg/m
2) 20.6±2.8 21.9±2.5 0.167
Cigarette smoking 0.775
Non-smoker 76 (97%) 28 (80%)
Ex-smoker 2 (3%) 6 (17%)
Current smoker 0 1 (3%)
Prior therapy for tuberculosis 44 (56%) 4 (11%) <0.001
Sinusitis 20 (26%) 35 (100%) <0.001
Symptoms
Cough 70 (91%) 35 (100%) 0.096
Sputum 71 (93%) 25 (100%) 0.178
Hemoptysis 43 (56%) 11 (31%) 0.017
Dyspnea 20 (26%) 34 (97%) <0.001
Coarse crackles 42 (54%) 35 (100%) <0.001
Table 1. Comparison of the clinical characteristics of patients
with the nodular bronchiectatic form of nontuberculous mycobac-
teria (NTM) lung disease with those with diffuse panbronchioli-
tis (DPB)
WBC, white blood cell count; RA, rheumatoid arthritis.
WBC cells/μ L 6,599±1837 9,251±2268 <0.001
CRP (mg/dL) 0.8±1.7 2.3±3.2 0.028
Hemoglobin (g/dL) 12.9±1.5 14.1±1.5 0.171
Albumin (g/dL) 3.8±0.3 3.9±0.4 0.179
RA factor (IU/mL) 18.1±13.0 19.8±5.7 0.597
IgA (mg/dL) 318.6±138.9 473.9±213.8 <0.001
IgG (mg/dL) 1,562.6±363.1 1,528.8±293.2 0.715
Cold hemagglutinin titer >64 1 (1%) 8 (23%) 0.002
FEV1/FVC <70% 27 (37%) 33 (94%) <0.001
PaO2 at room air <80 mmHg  23 (30%) 34 (97%) <0.001
Table 2. Comparison of the laboratory findings of patients with
the nodular bronchiectatic form of nontuberculous mycobacte-
ria (NTM) lung disease with those with diffuse panbronchiolitis
(DPB)
Fig. 1. Typical radiographic presentations of the nodular bronchiectatic form of nontuberculous mycobacterial lung disease and diffuse
panbronchiolitis. (A) A 57-yr-old woman with Mycobacterium avium lung disease. Axial image of chest CT shows tubular bronchiectasis
associated with lung volume loss in both right middle lobe and lingular division of the left upper lobe. Also note clustered centilobular
micronodules and branching linear opacities (tree-in-bud pattern) in the right lower lobe (arrows). (B) A 23-yr-old woman with diffuse pan-
brochiolitis. Axial image of c hest CT shows innumerable centrilobular micronodules and branching linear opacities or bronchioloectasis
in entire lung. Also note bronchiectasis in both right middle lobe and lingular division of the left upper lobe (arrows). 
A Bof patients with NTM lung disease and in all patients with
DPB (Table 3).
The most common HRCT findings were the presence of
bronchiectasis and bronchiolitis, which were seen in all pati-
ents with NTM lung disease and DPB. However, the involve-
ment of bronchiectasis and bronchiolitis on chest HRCT was
more extensive in patients with DPB. Bronchiectasis and
bronchiolitis were usually observed in more lobes in patients
with DPB than in those with NTM lung disease (P<0.001,
P<0.001, respectively) (Table 3) (Fig. 1). In patients with
DPB, the involvement of bronchiectasis and bronchiolitis in
the right middle lobe and both lower lobes was also more
common than in those with NTM lung disease (Table 4).
However, a cavity (or cavities) was more commonly found
in patients with NTM lung disease (23% vs. 0%, P=0.003).
DISCUSSION
The purpose of this study was to identify clinicoradiograph-
ic differences between the nodular bronchiectatic form of
NTM lung disease and DPB. We found that patients with
the nodular bronchiectatic form of NTM lung disease were
of an older age, had a female predilection, and were more like-
ly to have a history of tuberculous treatment, while patients
with DPB had sinusitis more frequently. Hemoptysis was
related to NTM lung disease, and exertional dyspnea and
coarse crackles were related to DPB. In patients with DPB,
marked obstructive abnormalities, hypoxemia, increased in-
flammatory laboratory findings, and more lobes involved
with bronchiectasis or bronchiolitis on HRCT were more
frequently observed.
The NTM lung disease has been differentiated into two
distinct subtypes, the upper lobe cavitary form and the nodu-
lar bronchiectatic form (1, 2). The nodular bronchiectatic
form was reported in more than half of NTM lung disease
cases and occurs predominantly in non-smoking, middle-aged
or elderly women without previous or underlying lung dis-
eases (1, 2). The radiographic findings show bilateral nodu-
lar or reticulonodular changes, particularly in the middle lobe
of the right lung and the lingular segment of the upper lobe
of the left lung (1, 2). In the present study, more than 80%
of patients with nodular bronchiectatic form of NTM lung
disease had involvement in the middle lobe of the right lung
and the lingular segment of the left lung on chest HRCT
scans.
Since the first comprehensive report of DPB was published
in 1983 (15), there has been dissemination of knowledge about
DPB. The diagnosis is based on the clinical and radiographic
findings, pulmonary function test, and laboratory findings
of patients as shown in the diagnostic criteria of the Ministry
of Health and Welfare of Japan (10). Our study evaluated
patients who fulfilled these diagnostic criteria. This is the
reason nearly 100% show exertional dyspnea, crackles, and
sinusitis in DPB. But, even in the nodular bronchiectatic
form of NTM lung disease, exertional dyspnea, crackles, and
sinusitis were observed in 26%, 54%, and 26% of patients,
respectively. As the diagnostic criteria reflect chronic respi-
ratory impairment, other laboratory findings suggest non-
specific inflammation (16). Our study also demonstrated the
increased value of WBC, CRP, and IgA in patients with DPB
NTM lung 
disease
DPB* Variables P value
Chest radiography (n=78) (n=34)
Cavity (or cavities) 5 (6%) 0 0.320
Reticulonodular opacities 78 (100%) 34 (100%) 1.000
Distribution 0.216
Upper lung zone (s) 0 0
Middle and/or lower  43 (55%) 23 (68%)
lung zone (s)
Both 35 (45%) 11 (32%)
Bilateral lung lesions 70 (90%) 34 (100%) 0.103
Chest HRCT (n=78) (n=32)
Cavity (or cavities) 18 (23%) 0 0.003
No. of involved lobes
Bronchiectasis 2.9±1.3 4.8±1.4 <0.001
Bronchiolitis 4.0±1.3 5.3±1.1 <0.001
Table 3. Comparison of chest radiography and HRCT findings
between patients with the nodular bronchiectatic form of nontu-
berculous mycobacteria (NTM) lung disease and those with
diffuse panbronchiolitis (DPB)
*Chest radiography was not available in one patient and chest HRCT
was not available in three patients with DPB.
HRCT, high-resolution computed tomography.
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NTM lung 
disease (n=78)
DPB*
(n=32)
Variables P value
Bronchiectasis
RUL 30 (39%) 17 (53%) 0.158
RML 64 (82%) 32 (100%) 0.010
RLL 26 (33%) 28 (88%) <0.001
LUL 13 (17%) 17 (53%) <0.001
LUL lingular 65 (83%) 28 (88%) 0.773
LLL 30 (39%) 30 (94%) <0.001
Bronchiolitis
RUL 42 (54%) 21 (66%) 0.257
RML 62 (80%) 32 (100%) 0.005
RLL 53 (68%) 32 (100%) <0.001
LUL 39 (50%) 22 (69%) 0.072
LUL lingular 65 (83%) 29 (91%) 0.389
LLL 52 (67%) 32 (100%) <0.001
Table 4. Comparison of the distribution of bronchiectasis and
bronchiolitis on chest HRCT between patients with the nodular
bronchiectatic form of nontuberculous mycobacteria (NTM)
lung disease and those with diffuse panbronchiolitis (DPB)
*Chest CT was not available in three patients with DPB.
HRCT, high-resolution computed tomography; RUL, right upper lobe;
RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL,
left lower lobe.and all of them were significantly higher than those with
nodular bronchiectatic form of NTM lung disease. As IgA
in immunoglobulin isotype is found predominantly in airway
secretion and has a protective effect of the mucosal immune
system against respiratory tract infection, increased IgA level
in DPB patients might suggest that DPB is more character-
ized by chronic airway inflammation (17).
A previous study reported that bilateral bronchiectasis,
especially combined with multiple small nodules and branch-
ing centrilobular nodular structures on chest HRCT, was asso-
ciated with NTM infections, followed by DPB (7). Our study
demonstrated that both groups had similar findings on the
chest radiography films, and bronchiectasis and bronchioli-
tis on chest HRCT without significant differences. However,
cavitary lesions were observed only in the nodular bronchiec-
tatic form of NTM lung disease, and the number of involved
lobes, especially bilateral lower lobes including the right mid-
dle lobe, was greater in DPB patients.
The importance of discriminating between the nodular
bronchiectatic form of NTM lung disease and DPB is because
of the different treatments for these diseases. In DPB, since
the introduction of erythromycin therapy by Kudoh in the
mid-1980s, the prognosis of DPB has changed from a fatal
to a curable disease (10, 13). Presently, low-dose and long-
term erythromycin monotherapy is established as the most
efficient treatment, and the clinicians start erythromycin as
soon as the patient is diagnosed (10). When erythromycin is
found ineffective, the newer macrolides, such as clarithromycin
or azithromycin are considered as the second choice. 
These macrolides are also important in the treatment of
NTM lung disease; especially MAC lung disease and M. absces-
sus lung disease. In addition to M. kansasii, MAC and M.
abscessus are the most commonly encountered pathogens and
more than half of patients with MAC or M. abscessus present
with the nodular bronchiectatic form on chest CT scans. Intro-
duction of the newer macrolides resulted in a major therapeu-
tic advance in the treatment of MAC lung disease (1, 2). When
a macrolide was administered alone, however, the organism
was more likely to acquire macrolide-resistance which was
strongly associated with a poor treatment outcome (14). Thus,
combination therapy including macrolides is recommended
for patients with MAC lung disease. In M. abscessus lung dis-
ease, macrolides are the only oral antibiotics this organism
is susceptible to, and macrolide monotherapy without other
intravenous antibiotics, such as cefoxitin, amikacin and imi-
penem cannot achieve negative sputum conversion (1, 2).
Hence, in NTM lung disease, if macrolide monotherapy is
prescribed as it is in DPB, it can lead to the acquisition of
macrolide-resistance of the NTM infection and even treat-
ment failure. In addition, patients with DPB are recommend-
ed for immediate treatment. While, as the course of NTM
pulmonary infections of the nodular bronchiectatic form can
be indolent, clinicians must determine when to start antibi-
otic treatment (1, 2).
In conclusion, this study demonstrates that some clinical
and radiographic findings are helpful in discriminating bet-
ween the nodular bronchiectatic form of NTM lung disease
and DPB. However, there is considerable overlap in the clin-
ical and radiographic appearances of nodular bronchiectatic
form of NTM lung disease and DPB. Still, there is no criti-
cal discriminating clinical or radiographic characteristics
between them that is as specific as the microbiologic docu-
mentation. The correct diagnosis, including aggressive micro-
biologic evaluation, should be made for the appropriate man-
agement of patients presenting with bilateral bronchiectasis
and bronchiolitis.
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